Network Insights Methodology Get Access

CEU

ORG Health Care / Biotechnology Momentum 9.3 NORMAL Primary: Spectral Shift

CEU operates in the biotechnology and pharmaceutical development sector. Recent signal activity clusters around rare disease therapeutics and biotech fundraising.

Entity appears in healthcare sector articles alongside pharmaceutical M&A activity including Angelini Pharma's $4.1B acquisition of Catalyst Pharmaceuticals and CNS Pharmaceuticals funding round.
-0.50
PSI Score
9.3
Momentum
1%
Confidence
1
Connections
Connected Entities
San Francisco
Watch This Entity
PSI Intelligence
30-Day Trend
2026-04-12 2026-05-12 1 0 Degree Mentions
Signal Decomposition
Attention Cascade
-0.316
Narrative Drift
0.000
Spectral Shift
537.064
Sentiment-Momentum Divergence
0.000
Source Concentration
1.000
Network Analysis
1 Degree Centrality
Centrality History
2026-04-12 2026-05-12 1 0 Degree Mentions
EntityWeight StatusFirst Seen
San Francisco 54 NEW
Article Coverage (0)
DateLaneTitle

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-05-12 ← Intelligence Network